FOLD
Amicus Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
4.23 / 10Overall Score
NeturalInvestment Rating
4.23 / 10Overall Score
NeturalInvestment Rating
Is FOLD a Buy, Sell, or Hold?
- Based on a composite score of 4.23/10, we rate FOLD as a Netural. Our analysis breaks down into 3.11/10 for Fundamentals, 4.42/10 for Technicals, and 4.71/10 for Sentiment, indicating the stock is likely to consolidate sideways.
What is the current technical signals for FOLD?
Is FOLD fundamentally strong?
What is the analyst consensus for FOLD?
Is FOLD a Buy, Sell, or Hold?
- Based on a composite score of 4.23/10, we rate FOLD as a Netural. Our analysis breaks down into 3.11/10 for Fundamentals, 4.42/10 for Technicals, and 4.71/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is FOLD fundamentally strong?
What is the current technical signals for FOLD?
What is the analyst consensus for FOLD?
